Document is current
Any future updates will be listed below
-
Authors
Balasubramanian, Preetha
Balaji, Uthra
Santos, Marina Silva https://orcid.org/0009-0009-8330-9858
Baisch, Jeanine https://orcid.org/0000-0002-6678-0308
Smitherman, Cynthia
Walters, Lynnette
Sparagana, Paola
Nassi, Lorien
Stewart, Katie
Fuller, Julie
Means, Terry
Savova, Virginia
Banchereau, Jacques F.
Wright, Tracey
Pascual, Virginia https://orcid.org/0000-0002-8806-8426
Gu, Jinghua https://orcid.org/0000-0003-2890-3183
Caielli, Simone https://orcid.org/0000-0001-6919-6791
- License Information
-
More Information
Article History
Received: 17 December 2024
Accepted: 5 September 2025
First Online: 21 October 2025
Competing interests
: V.P. has received consulting honoraria from Sanofi, AstraZeneca, Merk, Regeneron and Moderna. She is a Scientific Advisor for Moderna and Metis Therapeutics and has received a research grant from Sanofi and a contract from AstraZeneca. T.M. is an employee at Sanofi Pasteur. V.S. is an employee at AstraZeneca. In the early stage of the study, J.B. was a SAB member of Cue Biopharma. Currently, he is the founder of Immunoledge LLC, an entity designed to advise biotech start-ups. In this role, J.B. serves as CIO of Georgiamune, SAB member of Metis Therapeutics and advisor to the Jackson Laboratory. The other authors declare no competing interests.
